Specify Company / Ticker to Get the Summary
Dividend History CYCC
Dividend Analytics CYCC
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Cyclacel Pharmaceuticals Inc
CYCCCyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia. Address: Level 10, Kuala Lumpur, Malaysia, 592000
Analytics
WallStreet Target Price
1.00 USDP/E Ratio
0.19Dividend Yield
–Financials CYCC
Results | 2019 | Dynamics |